We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Amgen, Servier Collaborate

News   Sep 08, 2016

 
Amgen, Servier Collaborate
 
 
Advertisement
 

RELATED ARTICLES

Real-World Data Suggests Two Doses of Pfizer Vaccine Provides Over 95% Protection

News

An observational study published in The Lancet has explored the real-world effectiveness of the Pfizer–BioNTech mRNA COVID-19 vaccine (BNT162b2) against a variety of outcomes.

READ MORE

"Smart” Cell Therapies Designed To Treat Solid Tumors

News

Researchers have shown how to engineer smart immune cells that are effective against solid tumors, opening the door to treating a variety of cancers that have long been untouchable with immunotherapies.

READ MORE

Malaria Vaccine Shown To Be 77% Effective in Phase 2b Trial

News

Researchers from the University of Oxford and their partners have today reported findings from a Phase 2b trial of a candidate malaria vaccine, which demonstrated an efficacy of 77% over 12-months of follow-up.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE